I really don’t think TV advertising will have any effect whatsoever - all medical practitioners are well aware of the product and likewise any one with Low T.
Net sales last year in a nutshell:
Q1 2014: US$39.5m
Q2 2014: US$47.1m
Q3 2014: US$36.3m
Q4 2014: US$47.6m
- Global sales growing at a phenomenal rate.
- Axiron share of the topical testosterone market at end of 2014 was 13.7%.
We now have clarification regarding FDA and know that labelling and testing measures will be implemented. Apparently 80% were already having their testosterone levels checked before being prescribed TRT anyway. I believe this is encouraging and a lot more transparent and removes any ambiguity surrounding the product.
All augers well in my opinion and if we can edge past 50m in Q1, the likes of Justbob with no interest in the stock rather his own personal agendas will be running for cover… DYOR
Looming Axiron net sales results for Q1 - 2015, page-7
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.69M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 434 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 17258 | 1 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable